Evidence-based, reality-driven colorectal cancer screening guidelines the critical relationship of adherence to effectiveness

JAMA - Journal of the American Medical Association

Volumn 315, Issue 19, 2016, Pages 2065-2066

  Winawer, Sidney J ^a   Fischer, Sara E ^a   Levin, Bernard ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GUAIAC;

CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; DNA DETERMINATION; EVIDENCE BASED PRACTICE; FECES ANALYSIS; FEEDBACK SYSTEM; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MEDICAL INFORMATION; NOTE; OCCULT BLOOD TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMINDER SYSTEM; REPEAT PROCEDURE; SIGMOIDOSCOPY; UNITED STATES; ADVISORY COMMITTEE; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FEMALE; MALE; OCCULT BLOOD; PATIENT COMPLIANCE; STATISTICS AND NUMERICAL DATA; UTILIZATION;

ADVISORY COMMITTEES; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; DNA, NEOPLASM; EARLY DETECTION OF CANCER; EVIDENCE-BASED PRACTICE; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; OCCULT BLOOD; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIGMOIDOSCOPY; UNITED STATES;

EID: 84969142719     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.3377     Document Type: Note

References (10)

1. Levin B, Lieberman DA, McFarland B, et al; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5):1570-1595.
2. Winawer SJ. The history of colorectal cancer screening: A personal perspective. Dig Dis Sci.2015; 60(3):596-608.
3. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: A decision analysis for the US Preventive Services Task Force. Ann Intern Med. 2008;149(9): 659-669.
4. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening test use-United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(44):881-888.
5. US Preventive Services Task Force. Draft recommendation statement, colorectal cancer: screening. http://www .uspreventiveservicestaskforce.org/Page /Document/draft-recommendation -statement38/colorectal-cancer-screening2#tab. Accessed January 20, 2016.
6. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687-696.
7. Crotta S, Segnan N, Paganin S, Dagnes B, Rosset R, Senore C. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol. 2012;10(6): 633-638.
8. Gellad ZF, Stechuchak KM, Fisher DA, et al. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol. 2011;106(6): 1125-1134.
9. Jensen CD, Corley DA, Quinn VP, et al. Fecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort study. Ann Intern Med. 2016;164(7): 456-463.
10. Meester RG, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015;121(13):2281-2285.